Hugel Officially Launches Botulinum Toxin 'Letybo' in Malaysia

From Conference Participation to Hands-On Workshop

Hugel Co., Ltd. (Chairman: Cha Seokyong), a global total medical aesthetics company, has officially launched its botulinum toxin product 'Letybo' in Malaysia, an emerging market for medical aesthetics in Southeast Asia.

Hugel held a launch event for 'Letibo' at AMSC, the largest medical beauty conference in Malaysia, on the 6th. Photo by Hugel

On August 6 and 7, Hugel participated in AMSC (Aesthetic Medicine & Surgery Conference), the largest medical beauty conference in Malaysia, where it unveiled Letybo. Konstantin Frank, a representative KOL (Key Opinion Leader) for Letybo in Europe, attended as a speaker and shared clinical strategies for achieving precise treatment effects and enhancing the quality of outcomes with Letybo.

On August 8, Hugel also hosted a brand launch event and hands-on workshop at The Zenith Hotel in Kuantan, Malaysia, inviting approximately 100 local medical professionals. The workshop was organized as an educational program focused on toxin treatment techniques that combine anatomical understanding with clinical experience.

This event was held in collaboration with Hugel's local Malaysian partner, Venusys Medical Sdn Bhd (hereafter Venusys). Venusys is a distributor of medical aesthetic products based in Malaysia and Singapore and maintains partnerships with various global brands.

A Hugel representative stated, "Hugel plans to continue offering customized educational programs that can build trust with local medical professionals in Malaysia, based on strategic collaborations with our partners. Through these efforts, we aim to strengthen the premium toxin brand experience and further solidify our market position through rapid market entry."

This content was produced with the assistance of AI translation services.